{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T00:07:43Z","timestamp":1717286863085},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.therap.2023.07.006","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T09:06:43Z","timestamp":1690448803000},"page":"307-317","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictive factors for acceptance of a long-acting opiate substitution treatment studied through social representations and internalized stigma"],"prefix":"10.1016","volume":"79","author":[{"given":"Aur\u00e9lie","family":"Lacroix","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Puybaret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Vill\u00e9ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliette","family":"Zattoni-Leroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Cantaloube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Nubukpo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2023.07.006_bib0185","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/add.14636","article-title":"Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult outpatients with opioid use disorder","volume":"114","author":"Frost","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.therap.2023.07.006_bib0190","unstructured":"United Nations office on drugs and crime: world drug report 2019. https:\/\/wdr.unodc.org\/wdr2019\/. [Accessed 20 July 2023]."},{"key":"10.1016\/j.therap.2023.07.006_bib0195","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/pm\/pnw078","article-title":"Patients\u2019 perspectives on tapering of chronic opioid therapy: a qualitative study","volume":"17","author":"Frank","year":"2016","journal-title":"Pain Med"},{"key":"10.1016\/j.therap.2023.07.006_bib0200","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3109\/10826089709039377","article-title":"Abstinence fear in methadone maintenance withdrawal: a possible obstacle for getting off methadone","volume":"32","author":"Eklund","year":"1997","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.therap.2023.07.006_bib0205","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1080\/14656566.2017.1409722","article-title":"Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus","volume":"18","author":"Dematteis","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.therap.2023.07.006_bib0210","series-title":"Tableau de bord, traitements de substitution aux opiac\u00e9s","author":"Brisacier","year":"2017"},{"key":"10.1016\/j.therap.2023.07.006_bib0215","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/jamapsychiatry.2017.1874","article-title":"Effect of buprenorphine weekly depot (CAM2038) and hydromorphone blockade in individuals with opioid use disorder: a randomized clinical trial","volume":"74","author":"Walsh","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.therap.2023.07.006_bib0220","first-page":"397","article-title":"Substitution et m\u00e9susage\u00a0: l\u2019injection intraveineuse de bupr\u00e9norphine haut dosage","volume":"28","author":"Varescon","year":"2002","journal-title":"Encephale"},{"key":"10.1016\/j.therap.2023.07.006_bib0225","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.therap.2020.05.007","article-title":"Prolonged-release buprenorphine formulations: perspectives for clinical practice","volume":"75","author":"Chappuy","year":"2020","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2023.07.006_bib0230","series-title":"Les traitements de substitution vus par les patients. Quels sont les enseignements de leurs exp\u00e9riences\u202f? OFDT Focus \u2013 consommateurs et cons\u00e9quences","author":"Langlois","year":"2011"},{"key":"10.1016\/j.therap.2023.07.006_bib0235","series-title":"La stigamtisation en psychiatrie et en sant\u00e9 mentale","first-page":"264","author":"Giordana","year":"2010"},{"key":"10.1016\/j.therap.2023.07.006_bib0240","series-title":"Social representations: explorations in social psychology","first-page":"313Pp","author":"Moscovici","year":"2001"},{"key":"10.1016\/j.therap.2023.07.006_bib0245","first-page":"92","article-title":"Pratiques sociales et representation","volume":"47","author":"Abric","year":"1994","journal-title":"Formation Emploi"},{"key":"10.1016\/j.therap.2023.07.006_bib0250","series-title":"Salari\u00e9s face aux nouvelles technologies","first-page":"223","author":"Grize","year":"1987"},{"issue":"2\u20133","key":"10.1016\/j.therap.2023.07.006_bib0255","first-page":"42","article-title":"R\u00e9flexions sur le traitement de la notion de repr\u00e9sentation sociales en psychologie sociale. Communication","volume":"6","author":"Jodelet","year":"1984","journal-title":"Inf Medias Theories"},{"key":"10.1016\/j.therap.2023.07.006_bib0260","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/014107680209500205","article-title":"Stigma in psychiatry","volume":"95","author":"Gray","year":"2002","journal-title":"J R Soc Med"},{"key":"10.1016\/j.therap.2023.07.006_bib0265","series-title":"Stigmate\u00a0: les usages sociaux des handicaps","first-page":"176","author":"Goffman","year":"1975"},{"key":"10.1016\/j.therap.2023.07.006_bib0270","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/clipsy.9.1.35","article-title":"The paradox of self-stigma and mental illness","volume":"9","author":"Corrigan","year":"2002","journal-title":"Clin Psychol Sci Pract"},{"key":"10.1016\/j.therap.2023.07.006_bib0275","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/oxfordjournals.schbul.a007098","article-title":"Measuring mental illness stigma","volume":"30","author":"Link","year":"2004","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.therap.2023.07.006_bib0280","series-title":"Tendances r\u00e9centes sur la toxicomanie et les usages de drogues \u00e0 Paris\u202f: \u00e9tat des lieux en 2015","author":"Pfau","year":"2016"},{"key":"10.1016\/j.therap.2023.07.006_bib0285","series-title":"Les pratiques d\u2019injection en milieu festif \u2013 \u00e9tat des lieux en 2008","author":"Girard","year":"2008"},{"key":"10.1016\/j.therap.2023.07.006_bib0290","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/add.14941","article-title":"Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia","volume":"115","author":"Larance","year":"2020","journal-title":"Addiction"},{"key":"10.1016\/j.therap.2023.07.006_bib0295","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12954-019-0296-4","article-title":"Prolonged-release opioid agonist therapy: qualitative study exploring patients\u2019 views of 1-week, 1-month, and 6-month buprenorphine formulations","volume":"16","author":"Neale","year":"2019","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.therap.2023.07.006_bib0300","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/136346159703400204","article-title":"Explanatory Model Interview Catalogue (EMIC): framework for comparative study of illness","volume":"34","author":"Weiss","year":"1997","journal-title":"Transcult Psychiatry"},{"key":"10.1016\/j.therap.2023.07.006_bib0305","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.psychres.2003.08.008","article-title":"Internalized stigma of mental illness: psychometric properties of a new measure","volume":"121","author":"Boyd","year":"2003","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.therap.2023.07.006_bib0310","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.encep.2013.03.002","article-title":"Mesurer la stigmatisation per\u00e7ue chez les personnes souffrant de troubles psychiques\u00a0: traduction fran\u00e7aise, validation et adaptation de la Stigma Scale","volume":"39","author":"Morandi","year":"2013","journal-title":"Encephale"},{"key":"10.1016\/j.therap.2023.07.006_bib0315","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.comppsych.2013.06.005","article-title":"Internalized Stigma of Mental Illness (ISMI) scale: a multinational review","volume":"55","author":"Boyd","year":"2014","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.therap.2023.07.006_bib0320","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/schbul\/sbl016","article-title":"Toward understanding the insight paradox: internalized stigma moderates the association between insight and social functioning, hope, and self-esteem among people with schizophrenia spectrum disorders","volume":"33","author":"Lysaker","year":"2007","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.therap.2023.07.006_bib0325","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000335626","article-title":"Sociocultural perceptions and representations of dementia in Brazzaville. Republic of Congo: the EDAC survey","volume":"2","author":"Faure-Delage","year":"2012","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"10.1016\/j.therap.2023.07.006_bib0330","doi-asserted-by":"crossref","first-page":"108492","DOI":"10.1016\/j.drugalcdep.2020.108492","article-title":"Determinants of interest in extended-released buprenorphine: a survey among 366 French patients treated with buprenorphine or methadone","volume":"220","author":"Rolland","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.therap.2023.07.006_bib0335","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3917\/psyt.192.0045","article-title":"Recours aux traitements de substitution dans les sorties des addictions","volume":"19","author":"Simmat-Durand","year":"2013","journal-title":"Psychotropes"},{"key":"10.1016\/j.therap.2023.07.006_bib0340","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3389\/fpsyt.2019.00726","article-title":"Prevalence of coaddictions and rate of successful treatment among a French sample of opioid-dependent patients with long-term opioid substitution therapy: the OPAL study","volume":"10","author":"Grall-Bronnec","year":"2019","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.therap.2023.07.006_bib0345","first-page":"99","article-title":"Self-stigma and substance use: a systematic review","volume":"67","author":"Milan","year":"2022","journal-title":"Psychol Fr"},{"key":"10.1016\/j.therap.2023.07.006_bib0350","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1080\/17425247.2019.1649252","article-title":"What place for prolonged-release buprenorphine depot-formulation Buvidal\u00ae in the treatment arsenal of opioid dependence? Insights from the French experience on buprenorphine","volume":"16","author":"Vorspan","year":"2019","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.therap.2023.07.006_bib0355","first-page":"764","article-title":"Weekly and monthly subcutaneous buprenorphine depot formulations vs. daily sublingual buprenorphine with naloxone for treatment of opioid use disorder: a randomized clinical trial. JAMA Intern Med","volume":"178","author":"Lofwall","year":"2018"},{"key":"10.1016\/j.therap.2023.07.006_bib0360","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2147\/SAR.S266838","article-title":"Patient-reported outcomes, experiences and satisfaction with weekly and monthly injectable prolonged-release buprenorphine","volume":"11","author":"Parsons","year":"2020","journal-title":"Subst Abuse Rehabil"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595723001075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595723001075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T05:39:37Z","timestamp":1717220377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595723001075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0040595723001075"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2023.07.006","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive factors for acceptance of a long-acting opiate substitution treatment studied through social representations and internalized stigma","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2023.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}